Kevin Hay

9PUBLICATIONS
56CO-AUTHORS
Gene and molecular therapyCancer therapy (excl. chemotherapy and radiation therapy)HaematologyHaematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Jul 01, 2026
GPNMB-directed CAR T cell therapy against MiT/TFE-family fusion-driven solid tumors.

|Feb 26, 2026
Real-World Outcomes of Axicabtagene Ciloleucel for Treatment of Relapsed or Refractory Large B-Cell Lymphoma in Canada.

Christopher Lemieux, John Kuruvilla, Mona Shafey

|Nov 24, 2023
Hematopoietic Cell Transplantation Trends and Outcomes in Canada: A Registry-Based Cohort Study.

Matthew D Seftel, Ivan Pasic, Gaganvir Parmar

|Jan 22, 2021
Efficacy and safety of CD22 chimeric antigen receptor (CAR) T cell therapy in patients with B cell malignancies: a protocol for a systematic review and meta-analysis.

Komal Adeel, Nathan J Fergusson, Risa Shorr

|Jul 21, 2020
Building Canadian capacity for CAR-T cells in relapsed/refractory acute lymphoblastic leukaemia: a retrospective cohort study.

Roy Khalife, Joshua Montroy, Emma J M Grigor

|Feb 21, 2019
The response to lymphodepletion impacts PFS in patients with aggressive non-Hodgkin lymphoma treated with CD19 CAR T cells.

Alexandre V Hirayama, Jordan Gauthier, Kevin A Hay

Pageof 2

Frequent Collaborators

3 joint publications

Stanley R Riddell

3 joint publications

David G Maloney

3 joint publications

Cameron J Turtle

2 joint publications

Hans-Peter Kiem